Colombia Pharmaceuticals and Healthcare Report Q2 2015

Business Monitor International
February 11, 2015
123 Pages - SKU: BMI5466924
Countries covered: Colombia

Colombia Pharmaceuticals and Healthcare Report Q2 2015

BMI View: President Juan Manuel Santos continues to push forward healthcare reform for medicine pricecontrols and regulatory reformation. Though, such reforms still leave scepticism as Colombia's strugglingeconomy and expanding counterfeit drug market continue to hinder progress for the Colombian governmentand pharmaceutical market.

Headline Expenditure Projections

Pharmaceuticals: COP8,643bn (USD4.38bn) in 2014 to COP9,118bn (USD4.3bn) in 2015; +5.5% inlocal currency terms and -2.1% in US dollar terms. Local currency forecast revised upward from Q115due to increased inflation and currency depreciation. US dollar forecast revised downward from Q115due to increased Colombian inflation and currency depreciation.



More Prescription Drugs reports by Business Monitor International

Slovenia Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Slovenia Pharmaceuticals and Healthcare Report Q2 2015BMI View: Our updated forecasts for Slovenia's pharmaceutical and healthcare expenditure indicate arebound this year from a decline trend ...
Romania Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Romania Pharmaceuticals and Healthcare Report Q2 2015BMI View: We expect Romania's pharmaceutical market in 2015 to be initially driven by a consumer-ledrecovery as falling fuel ...
Myanmar Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Myanmar Pharmaceuticals and Healthcare Report Q2 2015BMI View: New investment reforms lifting restrictions on the foreign funding of medicine production willmake Myanmar an attractive market ...
Lebanon Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Lebanon Pharmaceuticals and Healthcare Report Q2 2015BMI View: Lebanon's healthcare system is under enormous strain as the number of Syrian refugees seekingtreatment in the country ...
See all reports like this >>

More Colombia Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Colombia Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Colombia Q4 2014BMI View: Revenue recorded by multinational pharmaceutical companies will continue to be constrainedin Colombia over the coming years ...
Pharmaceuticals and Healthcare : Colombia Pharmaceuticals and Healthcare Report Q3 2014 by Business Monitor International
Pharmaceuticals and Healthcare : Colombia Pharmaceuticals and Healthcare Report Q3 2014BMI View: Revenue recorded by multinational pharmaceutical companies will continue to be constrainedin Colombia over ...
Antibiotics Market in Colombia to 2016 by Global Research & Data Services Oy
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Colombia. The study provides essential market ...
The Pharmaceutical Market: Colombia by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!